An Epidemic Supplanted by a Pandemic: Vaping-Related Illness and COVID-19

Before the coronavirus disease 2019 (COVID-19) pandemic, vaping-related illness was the prevailing public health concern. The incidence of vaping-related illnesses-mainly e-cigarette, or vaping, product use-associated lung injury (EVALI)-went from a peak in September 2019 to a low in February 2020,...

Full description

Saved in:
Bibliographic Details
Published inSouthern medical journal (Birmingham, Ala.) Vol. 115; no. 1; p. 8
Main Authors Shin, Yoo Mee, Hunt, Daniel P, Akwe, Joyce
Format Journal Article
LanguageEnglish
Published United States 01.01.2022
Subjects
COVID-19 - prevention & control
COVID-19 - psychology
Humans
Lung Injury - epidemiology
Lung Injury - etiology
Vaping - adverse effects
Vaping - trends
Online AccessGet more information

Cover

More Information
Summary:Before the coronavirus disease 2019 (COVID-19) pandemic, vaping-related illness was the prevailing public health concern. The incidence of vaping-related illnesses-mainly e-cigarette, or vaping, product use-associated lung injury (EVALI)-went from a peak in September 2019 to a low in February 2020, and the Centers for Disease Control and Prevention decided to discontinue the collection of EVALI case reports. Despite the decrease in EVALI with the arrival of COVID-19, EVALI should still be considered a differential diagnosis for people with COVID-19 for reasons outlined in this review. This narrative review describes vaping devices, summarizes the adverse health effects of vaping on the lungs and other systems, considers the potential interplay between vaping and COVID-19, and highlights gaps in knowledge about vaping that warrant further research.
ISSN:1541-8243
DOI:10.14423/SMJ.0000000000001344